These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15251635)

  • 1. Role of insulin-glucose infusion in outcomes after acute myocardial infarction: the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study.
    Malmberg K
    Endocr Pract; 2004; 10 Suppl 2():13-6. PubMed ID: 15251635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
    Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
    Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt P; MacLeod K; Laakso M; Torp-Pedersen C; Waldenström A;
    Eur Heart J; 2005 Apr; 26(7):650-61. PubMed ID: 15728645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.
    Malmberg K; Rydén L; Efendic S; Herlitz J; Nicol P; Waldenström A; Wedel H; Welin L
    J Am Coll Cardiol; 1995 Jul; 26(1):57-65. PubMed ID: 7797776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study.
    Malmberg K; Norhammar A; Wedel H; Rydén L
    Circulation; 1999 May; 99(20):2626-32. PubMed ID: 10338454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. A report from the multicenter trial: DIGAMI.
    Malmberg KA; Efendic S; Rydén LE
    Diabetes Care; 1994 Sep; 17(9):1007-14. PubMed ID: 7988298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction): theory and practice.
    Davies MJ; Lawrence IG
    Diabetes Obes Metab; 2002 Sep; 4(5):289-95. PubMed ID: 12190991
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group.
    Malmberg K
    BMJ; 1997 May; 314(7093):1512-5. PubMed ID: 9169397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction.
    Malmberg K; Rydén L; Hamsten A; Herlitz J; Waldenström A; Wedel H
    Eur Heart J; 1996 Sep; 17(9):1337-44. PubMed ID: 8880018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin-glucose infusion on mortality following acute myocardial infarction in patients with diabetes: the diabetes and insulin-glucose infusion in acute myocardial infarction studies.
    Malmberg K; Rydén L
    Semin Thorac Cardiovasc Surg; 2006; 18(4):326-9. PubMed ID: 17395029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study.
    Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
    Diabetologia; 2011 Jun; 54(6):1308-17. PubMed ID: 21359582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial.
    Mellbin LG; Malmberg K; Rydén L; Wedel H; Vestberg D; Lind M
    Eur Heart J; 2013 Feb; 34(5):374-9. PubMed ID: 23144046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].
    Gustafsson I; Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt PR; MacLeod K; Laakso M; Torp-Pedersen CT; Waldenström A;
    Ugeskr Laeger; 2006 Feb; 168(6):581-4. PubMed ID: 16476220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of intensive insulin therapy after an acute myocardial infarction in patients with type 2 diabetes: results of the DIGAMI-2 trial].
    Scheen AJ; Radermecker RP; Philips JC
    Rev Med Liege; 2004 Sep; 59(9):534-9. PubMed ID: 15559444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial.
    Mellbin LG; Malmberg K; Waldenström A; Wedel H; Rydén L;
    Heart; 2009 May; 95(9):721-7. PubMed ID: 19029171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study.
    Malmberg K; Rydén L; Hamsten A; Herlitz J; Waldenström A; Wedel H
    Cardiovasc Res; 1997 Apr; 34(1):248-53. PubMed ID: 9217897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction.
    Cheung NW; Wong VW; McLean M
    Diabetes Care; 2006 Apr; 29(4):765-70. PubMed ID: 16567812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical potential of insulin therapy in critically ill patients.
    Mesotten D; Van den Berghe G
    Drugs; 2003; 63(7):625-36. PubMed ID: 12656643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose and insulin management in the post-MI setting.
    McNulty PH
    Curr Diab Rep; 2002 Feb; 2(1):37-44. PubMed ID: 12643121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of strict metabolic control by insulin infusion on fibrinolytic profile during an acute coronary event in diabetic patients.
    Melidonis A; Stefanidis A; Tournis S; Manoussakis S; Handanis S; Zairis M; Dadiotis L; Foussas S
    Clin Cardiol; 2000 Mar; 23(3):160-4. PubMed ID: 10761802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.